Eradication of multiple myeloma and breast cancer cells by TH9402-mediated photodynamic therapy: Implication for clinical ex vivo purging of autologous stem cell transplants

Photochemistry and Photobiology

Volumn 72, Issue 6, 2000, Pages 780-787

  Brasseur, N ^c   Menard I ^a   Forget, A ^c   El Jastimi, R ^a   Hamel, R ^a   Molfino, N A ^a   Van Lier, J E ^b  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

4,5 DIBROMORHODAMINE METHYL ESTER; PHOTOSENSITIZING AGENT; TH 9402; UNCLASSIFIED DRUG;

APHERESIS; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BREAST CARCINOMA; CANCER CELL CULTURE; CONTROLLED STUDY; DILUTION; DRUG UPTAKE; FLUOROSCOPY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INCUBATION TIME; MULTIPLE MYELOMA; PHOTODYNAMIC THERAPY; PHOTOINHIBITION; PRECURSOR CELL; RADIATION DOSE; SPECTROFLUOROMETRY;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0034593265     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/0031-8655(2000)072<0780:EOMMAB>2.0.CO;2     Document Type: Article

References (58)

1. Fermand, J. P., P. Ravaud, S. Chevret, V. Leblond, M. Divine, F. Dreyfus, C. Belanger, X. Troussard, X. Mariette and J. C. Brouet (1995) High-dose therapy and autologous blood stem cell transplantation in multiple myeloma: preliminary results of a randomized trial involving 167 patients. Stem Cells 13(Suppl. 2), 156-159.
2. Harousseau, J. L. and M. Attal (1997) The role of autologous hematopoietic stem cell transplantation in multiple myeloma. Semin. Hematol. 34, 61-66.
3. McCauley, D. L. (1996) High-dose chemotherapy with stem-cell rescue for the treatment of breast cancer. Am. J. Health Syst. Pharm. 53, 521-534 (quiz 561-522).
4. Lazarus, H. M. (1998) Hematopoietic progenitor cell transplantation in breast cancer: Current status and future directions. Cancer Investig. 16, 102-126.
5. Stadtmauer, E. A., A. O'Neill, L. J. Goldstein, P. Crilley, K. R. Mangan, J. N. Ingle, H. M. Lazarus, J. Erban, C. Sickles and J. H. Glick. Phase III randomized trial of high-dose chemotherapy (HDC) and stem cell support (SCT) shows no difference in overall survival or severe toxicity compared to maintenance chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) for women with metastatic breast cancer who are responding to conventional induction chemotherapy: the "Philadelphia" intergroup study (BPT-1)., Abstract, 35th Annual Meeting of the American Society of Clinical Oncology, 1999, Atlanta, GA.
6. Ross, A. A., B. W. Cooper, H. M. Lazarus, W. Mackay, T. J. Moss, N. Ciobanu, M. S. Tallman, M. J. Kennedy, N. E. Davidson, D. Sweet, C. Winter, L. Akard, J. Jansen, E. Copelan, R. C. Meagher, R. H. Herzig, T. R. Klumpp, D. G. Kahn and N. E. Warner (1993) Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82, 2605-2610. [see comments]
7. Brugger, W., K. J. Bross, M. Glatt, F. Weber, R. Mertelsmann and L. Kanz (1994) Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83, 636-640. [see comments]
8. Rill, D. R., V. M. Santana, W. M. Roberts, T. Nilson, L. C. Bowman, R. A. Krance, H. E. Heslop, R. C. Moen, J. N. Ihle and M. K. Brenner (1994) Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84, 380-383.
9. Simpson, S. J., M. Vachula, M. J. Kennedy, H. Kaizer, J. S. Coon, R. Ghalie, S. Williams and D. Van Epps (1995) Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometry. Exp. Hematol. 23, 1062-1068.
10. Schulze, R., M. Schulze, A. Wischnik, S. Ehnle, K. Doukas, W. Behr, W. Ehret and G. Schlimok (1997) Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients. Bone Marrow Transplant. 19, 1223-1228.
11. Vannucchi, A. M., A. Bosi, S. Glinz, P. Pacini, S. Linari, R. Saccardi, R. Alterini, L. Rigacci, S. Guidi, L. Lombardini, G. Longo, M. P. Mariani and P. Rossi-Ferrini (1998) Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT-PCR for cytokeratin-19 mRNA. Br. J. Haematol. 103, 610-617.
12. Vescio, R. A., E. J. Han, G. J. Schiller, J. C. Lee, C. H. Wu, J. Cao, J. Shin, A. Kim, A. K. Lichtenstein and J. R. Berenson (1996) Quantitative comparion of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts. Bone Marrow Transplant. 18, 103-110.
13. Dreyfus, F., J. Melle, C. C. Quarre and C. Pillier (1993) Contamination of peripheral blood by monoclonal B cells following treatment of multiple myeloma by high-dose chemotherapy. Br. J. Haematol. 85, 411-412.
14. Mariette, X., J. P. Fermand and J. C. Brouet (1994) Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated by high-dose therapy. Bone Marrow Transplant. 14, 47-50.
15. Corradini, P., C. Voena, M. Astolfi, M. Ladetto, C. Tarella, M. Boccadoro and A. Pileri (1995) High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting. Blood 85, 1596-1602.
16. Corradini, P., C. Voena, C. Tarella, M. Astolfi, M. Ladetto, A. Palumbo, M. T. Van Lint, A. Bacigalupo, A. Santoro, M. Musso, I. Majolino, M. Boccadoro and A. Pileri (1999) Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells. J. Clin. Oncol. 17, 208-215.
17. Kiel, K., F. W. Cremer, C. Rottenburger, C. Kallmeyer, E. Ehrbrecht, A. Atzberger, U. Hegenbart, H. Goldschmidt and M. Moos (1999) Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation. Bone Marrow Transplant. 23, 1019-1027.
18. Schiller, G., R. Vescio, C. Freytes, G. Spitzer, F. Sahebi, M. Lee, C. H. Wu, J. Cao, J. C. Lee, C. H. Hong, A. Lichtenstein, M. Lill, J. Hall, R. Berenson (1995) Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 86, 390-397.
19. Lemoli, R. M., A. Fortuna, M. R. Motta, S. Rizzi, V. Giudice, A. Nannetti, G. Martinelli, M. Cavo, M. Amabile, S. Mangianti, M. Fogli, R. Conte and S. Tura (1996) Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells. Blood 87, 1625-1634.
20. Roots-Weiss, A., C. Papadimitriou, H. Serve, B. Hoppe, M. Koenigsmann, B. Reufi, D. Oberberg, E. Thiel and W. E. Berdel (1997) The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems. Bone Marrow Transplant. 19, 1239-1246.
21. Abonour, R., K. M. Scott, L. A. Kunkel, M. J. Robertson, R. Hromas, V. Graves, E. N. Lazaridis, L. Cripe, V. Gharpure, C. M. Traycoff, B. Mills, E. F. Srour and K. Cornetta (1998) Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myeloma. Bone Marrow Transplant. 22, 957-963.
22. Mohr, M., E. Hilgenfeld, T. Fietz, B. Hoppe, M. Koenigsmann, M. Hoffmann, W. U. Knauf, U. Cassens, W. Sibrowski, J. Kienast, E. Thiel and W. E. Berdel (1999) Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy. Clin Cancer Res. 5, 1035-1040.
23. Brenner, M. K., D. R. Rill, R. C. Moen, R. A. Krance, J. Mirro, Jr., W. F. Anderson and J. N. Ihle (1993) Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341, 85-86.
24. Deisseroth, A. B., Z. Zu, D. Claxton, E. G. Hanania, S. Fu, D. Ellerson, L. Goldberg, M. Thomas, K. Janicek, W. F. Anderson, J. Hester, M. Korbling, A. Durett, R. Moen, R. Berenson, S. Heimfeld, J. Hamer, L. Calvert, P. Tibbits, M. Talpaz, H. Kantarjian, R. Champlin and C. Reading (1994) Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83, 3068-3076.
25. Villeneuve, L. (1999) Ex vivo photodynamic purging in chronic myelogenous leukaemia and other neoplasias with rhodamine derivatives. Biotechnol. Appl. Biochem. 30, 1-17.
26. Shpall, E. J., S. M. Stemmer, L. Hami, W. A. Franklin, L. Shaw, H. S. Bonner, S. I. Bearman, W. P. Peters, R. C. Bast, Jr., W. McCulloch R. Capizzi, E. Mitchell, P. S. Schein, and R. B. Jones (1994) Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support. Blood 83, 3132-3137.
27. Lampidis, T. J., S. D. Bernal, I. C. Summerhayes and L. B. Chen (1983) Selective toxicity of rhodamine 123 in carcinoma cells in vitro. Cancer Res. 43, 716-720.
28. Davis, S., M. J. Weiss, J. R. Wong, T. J. Lampidis and L. B. Chen (1985) Mitochondrial and plasma membrane potentials cause unusual accumulation and retention or rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. J. Biol. Chem. 260, 13 844-13 850.
29. Oseroff, A. R., D. Ohuoha, G. Ara, D. McAuliffe, J. Foley and L. Cincotta (1986) Intramitochondrial dyes allow selective in vitro photolysis of carcinoma cells. Proc. Natl. Acad. Sci. USA 83, 9729-9733.
30. Udomsakdi, C., C. J. Eaves, H. J. Sutherland and P. M. Lansdorp (1991) Separation of functionally distinct subpopulations of primitive human hematopoietic cells using rhodamine-123. Exp. Hematol. 19, 338-342.
31. Chow, A. J. Kennedy, R. Pottier and T. J. Truscott (1986) Rhodamine 123 - photophysical and photochemical properties. Photobiochem. Photobiophys. 11, 139-148.
32. Morlière, P., R. Santus, M. Bazin, E. Kohen, V. Carillet, F. Bon, J. Rainasse and L. Dubertret (1990) Is rhodamine 123 a photosensitizer? Photochem. Photobiol. 52, 703-710.
33. Sharman, W. S., C. M. Allen and J. E. van Lier (2000) Role of activated oxygen species in photodynamic therapy. Methods Enzymol. 319, 376-400.
34. Pal, P., H. Zeng, G. Durocher, D. Girard, T. Li, A. K. Gupta, R. Giasson, L. Blanchard, L. Gaboury, A. Balassy, C. Turmel, A. Laperrière and L. Villeneuve (1996) Phototoxicity of some bromine-substituted rhodamine dyes: synthesis, photophysical properties and application as photosensitizers. Photochem. Photobiol. 63, 161-168.
35. Roy, D. C., M. Felix, W. G. Cannady, S. Cannistra and J. Ritz (1990) Comparative activities of rabbit complements of different ages using an in-vitro marrow purging model. Leuk. Res. 14, 407-416.
36. Taswell, C. (1981) Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126, 1614-1619.
37. Sieber, F., R. K. Stuart, S. D. Rowley, S. J. Sharkis and L. L. Sensenbrenner (1987) Dye-mediated photolysis of normal and neoplastic hematopoietic cells. Leuk. Res. 11, 43-49.
38. Siber, F. (1993) Phototherapy, photochemotherapy, and bone marrow transplantation. J. Hematother. 2, 43-62.
39. Yamazaki, T. and F. Sieber (1997) The alkyl-lysophospholipid, ET-18-OCH3 synergistically enhances the Merocyanine 540-mediated photoinactivation of leukemia cells: implications for the extracorporeal purging of autologous hematopoietic stem cells [published erratum appears in Bone Marrow Transplant. 1997 20 (1), 95[. Bone Marrow Transplant. 19, 113-119.
40. Gulliya, K. S., M. Batagllino and J. L. Matthews (1990) Breast cancer and laser photoradiation therapy: and in vitro model for autologous bone marrow purging. In Bone Marrow Purging and Processing (Edited by S. Gross, A. P. Gee and D. A. Worthington-White), pp. 103-107. Alan R. Liss, New York.
41. Jamieson, C., A. Richter and J. G. Levy (1993) Efficacy of benzoporphyrin derivative, a photosensitizer, in selective destruction of leukemia cells using a murine tumor model. Exp. Hematol. 21, 629-634.
42. Lemoli, R. M., T. Igarashi, M. Knizewski, L. Acaba, A. Richter, A. Jain, D. Mitchell, J. Levy and S. C. Gulati (1993) Dye-mediated photolysis is capable of eliminating drug-resistant (MDR+) tumor cells. Blood 81, 793-800.
43. Levy, J. G., C. Dowding, D. Mitchell, R. Sorrenti, S. Yip and C. Jamieson (1995) Selective elimination of malignant stem cells using photosensitizers followed by light treatment. Stem Cells 13, 336-343.
44. Glück, S., A. Chadderton and A. D. Ho (1996) The selective uptake of benzoporphyrin derivative mono-acid ring A results in differential cell kill of multiple cells in vitro. Photochem. Photobiol. 63, 846-853.
45. Atzpodien, J., S. C. Gulati, A. Strife and B. D. Clarkson (1987) Photoradiation models for the clinical ex vivo treatment of autologous bone marrow grafts. Blood 70, 484-489.
46. Singer, C. R., D. C. Linch, S. G. Bown, E. R. Huehns and A. H. Goldstone (1988) Differential phthalocyanine photosensitization of acute myeloblastic leukaemia progenitor cells: a potential purging technique for autologous bone marrow transplantation. Br. J. Haematol. 68, 417-422.
47. Preti, R. A., M. Fitzgerald, J. F. Keij, J. W. M. Visser and E. Ben-Hur (1995) Photolytic purging of SK-BR3 and HL-60 tumor cells with the phthalocyanin, Pc4. J. Hematother. 4, 246.
48. Grebenova, D., H. Cajthamlova, K. Holada, J. Marinov, M. Jirsa and Z. Hrkal (1997) Photpdynamic effects of meso-tetra (4-sulfonatophenyl)porphine on human leukemia cells HEL and HL60, human lymphocytes and bone marrow progenitor cells. J. Photochem. Photobiol. B: Biol. 39, 269-278.
49. Daziano, J. P., L. Humeau, M. henry, P. Mannoni, M. Chanon, C. Chabannon and M. Julliard (1998) Preferential photoinactivation of leukemia cells by aluminum phthalocyanine. J. Photochem. Photobiol. B: Biol. 43, 128-135.
50. Fibach, E., S. A. Rabia and S. Gatt (1992) Pyrene butanol-an efficient, selective and non-metabolized photosensitizing agent for human myeloid leukemia cells. Leuk. Res. 16, 453-462.
51. Grebenova, D., H. Cajthamlova, J. Bartosova, J. Marino, H. Klamova, O. Fuchs and Z. Hrkal (1998) Selective destruction of leukaemic cells by photo-activation of 5-aminolaevulinic acid-induced protoporphyrin-IX. J. Photochem. Photobiol. B: Biol. 47, 74-81.
52. Sieber, F., J. M. O'Brien and D. K. Gaffney (1992) Antiviral effects of photosensitizing merocyanine dyes: implications for transfusion and bone marrow transplantation. Semin. Hematol. 29, 79-87.
53. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, Kessel, M. Korbelik, J. Moan and Q. Peng (1998) Photodynamic therapy. JNCI 90, 889-905.
54. Brown, S., R. Bonnet, R. Pottier, N. Brasseur and G. Jori (2000) Sensitizers for photodynamic therapy. In Photodynamic Therapy (Edited by G. Jori and T. Patrice). Elsevier, Amsterdam. (In press)
55. Guimond, M., S. Brochu, C. Perreault, N. Molfino and D. C. Roy. Specific eradication of host-reactive donor T cells can be achieved by a photodynamic treatment strategy. Seventh Conference of the Canadian Blood and Marrow transplant Group, April 2000, Québec, Canada.
56. Roy, D. C., Y. Paquette, A. Balassy, L. Villeneuve, N. Beauger, L. Blanchard, O. Giorgi, I. Gladu, R. Hamel, C. Perreault and N. Molfino (2000) Elimination of chronic myeloid leukemia (CML) cells with a novel photodynamic treatment. Blood 94, 144a. [Abstract]
57. Hilf, R., P. Bo Leakey, S. J. Sollot and S. L. Gibson (1983) Photodynamic inactivation of R3230AC mammary carcinoma in vitro with hematoporphyrin derivative: effects of dose, time and serum on uptake and phototoxicity. Photochem. Photobiol. 37, 633-642.
58. Brasseur, N., H. Ali, D. Autenrieth, R. Langlois and J. E. van Lier (1985) Biological activities of phthalocyanines. III. Photoinactivation of V-79 Chinese Hamster cells by tetrasulfophthalocyanines. Photochem. Photobiol. 40, 515-521.